harvard medical school curriculum vitae · 2015-2016 technical expert panel, inpatient psychiatric...

23
1 Harvard Medical School Curriculum Vitae Date Prepared: January 10, 2017 Name: Alisa B. Busch Office Address: McLean Hospital 115 Mill Street Administration Building, Room 107 Belmont, MA 02478 United States Home Address: 157 Middlesex Rd. Chestnut Hill, MA 02478 Work Phone: (617) 855-2989 Work Email: [email protected] [email protected] Work FAX: (617) 855-2574 Place of Birth: Philadelphia, PA Education 1990 B.A. (English Literature), New York University College of Arts and Science 1994 M.D., Johns Hopkins University School of Medicine 2000 M.S. (Health Policy and Management), Harvard School of Public Health Postdoctoral Training 07/94-06/95 Intern, Medicine-Psychiatry, The Johns Hopkins Bayview Medical Center 07/95-06/98 Resident, Psychiatry, The Johns Hopkins Hospital Department of Psychiatry and Behavioral Sciences 07/98-06/00 Postdoctoral Fellow, Mental Health Policy and Mental Health Services Research, Department of Health Care Policy, Harvard Medical School Faculty Academic Appointments 1998-2000 Research Fellow in Health Care Policy, Department of Health Care Policy, Harvard Medical School 2000-2001 Lecturer on Health Care Policy, Department of Health Care Policy, Harvard Medical School 2000-2007 Instructor in Psychiatry, Department of Psychiatry, Harvard Medical School 2006-2007 Instructor in Health Care Policy, Department of Health Care Policy, Harvard Medical School 2007- Assistant Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School 2007- Assistant Professor of Psychiatry, Department of Psychiatry, Harvard Medical School

Upload: others

Post on 23-Jun-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

1

Harvard Medical School Curriculum Vitae

Date Prepared January 10 2017

Name Alisa B Busch

Office Address McLean Hospital 115 Mill Street Administration Building Room 107 Belmont MA 02478 United States

Home Address 157 Middlesex Rd Chestnut Hill MA 02478

Work Phone (617) 855-2989

Work Email abuschpartnersorg

abuschhcpmedharvardedu

Work FAX (617) 855-2574

Place of Birth Philadelphia PA

Education

1990 BA (English Literature) New York University College of Arts and Science 1994 MD Johns Hopkins University School of Medicine 2000 MS (Health Policy and Management) Harvard School of Public Health

Postdoctoral Training 0794-0695 Intern Medicine-Psychiatry The Johns Hopkins Bayview Medical Center 0795-0698 Resident Psychiatry The Johns Hopkins Hospital Department of Psychiatry and Behavioral

Sciences 0798-0600 Postdoctoral Fellow Mental Health Policy and Mental Health Services Research

Department of Health Care Policy Harvard Medical School

Faculty Academic Appointments 1998-2000 Research Fellow in Health Care Policy Department of Health Care Policy Harvard Medical

School 2000-2001 Lecturer on Health Care Policy Department of Health Care Policy Harvard Medical School 2000-2007 Instructor in Psychiatry Department of Psychiatry Harvard Medical School 2006-2007 Instructor in Health Care Policy Department of Health Care Policy Harvard Medical School 2007- Assistant Professor of Health Care Policy Department of Health Care Policy Harvard

Medical School 2007- Assistant Professor of Psychiatry Department of Psychiatry Harvard Medical School

2

Appointments at HospitalsAffiliated Institutions 0700-0809 Psychiatrist-in-Charge Partial Hospital Program Alcohol and Drug Abuse Treatment

Program McLean Hospital 0700-0607 Assistant Psychiatrist McLean Hospital 0707- Associate Psychiatrist McLean Hospital

Other Professional Positions 1991 Ensign US Public Health Service Junior Commissioned Officer Student Training Extern

Program SA-Lantic Community Health Center Hammonton NJ 1997 Administrative Resident The Johns Hopkins Department of Psychiatry and Behavioral

Science Baltimore MD 1998-1999 Emergency Room Psychiatrist Cambridge Hospital Cambridge MA 1999-2001 Consultant in Quality Management Methodology Metropolitan Suburban Area Office

Office of the Area Medical Director Medfield MA 2000-2001 Consultant American Psychiatric Association Washington DC 2001-2003 Member Content Review Board Strategic Institute for Continuing Health Care Education

Strategic Implications International 2004-2005 Consultant RTI International Research Triangle Park NC Major Administrative Leadership Positions Local

2009-2015 Director Integration of Clinical Measurement amp Health Services Research

McLean Hospital

2009-2015 Electronic Medical Record Physician ldquoChampionrdquo (physician leading the implementation but not necessarily someone with informatics experience)

McLean Hospital

2011- Chief Health Services Research Division Partners Psychiatry amp Mental Health Partners HealthCare

2013- eCare Clinical Site ldquoChampionrdquo McLean Hospital 2016- Chief Medical Information Officer McLean Hospital 2016- Director Clinical Performance

Measurement amp Health Services Research McLean Hospital

Committee Service 2007 Bipolar and Psychotic Disorders Evidence

Based Reviews Domain Group McLean Hospital

2008 Strategic Task Force on Information Systems Master Plan

McLean Hospital

2008 Strategic Task Force on Practice-Based Evidence

McLean Hospital

2009-2015 Meditech Steering Committee McLean Hospital 2009- Continuous Quality Improvement

Committee McLean Hospital

2009-2013 Compliance Committee McLean Hospital 2009- Information Technology Steering McLean Hospital

3

Committee 2009- General Executive Committee McLean Hospital 2009-2013 Confidentiality Steering Committee Partners HealthCare 2009-2013 Partners Psychiatry amp Mental Health

Confidentiality Steering Committee Partners Psychiatry amp Mental Health

2009- Executive Committee of the Patient Care Assessment Committee

McLean Hospital

2009- Meditech Computerized Physician Order Entry MD Committee 2009-

McLean Hospital Committee Chair

2009-2011 Compliance Audit Committee 2009-2011

McLean Hospital Committee Chair

2009-2013 Medical Records Committee 2009-2013

McLean Hospital Committee Chair

2010- Clinical Quality Steering Committee Partners Psychiatry amp Mental Health 2010-2015 Committee Member 2016- Committee Co-Chair 2011-2012 Enterprise Medical Record Information

System Steering Committee Partners HealthCare

2013- McLean Hospital eCare Executive Committee

McLean Hospital Co-Chair

2015- eCare Operations Committee McLean Hospital 2013- eCare Research Council Partners HealthCare 2013- eCare Research Council Sub-committees Partners HealthCare 2013-2014 Behavioral Health Assessment 2013-2014 Governance Co-Chair since 2014 2014 Big Data 2013- eCare Privacy Workgroup Partners HealthCare 2014- eCare Clinical Decision Support Committee Partners HealthCare 2014- Partners Psychiatry amp Mental Health

Clinical Decision Support Workgroup Chair

2014- eCare Patient Engagement Committee Partners HealthCare 2014- Research Subcommittee Co-Chair 2014- Suicide Assessment Planning Committee McLean Hospital National and International

2003-2010 Research Network on Mandated Community Treatment 2003-2008 2008-2010

MacArthur Foundation Network Associate Network Member

2009 Committee on the Qualifications of Professionals Providing Mental Health Counseling Services Under TRICARE

Institute of Medicine Committee Member

2010-2012 Technical Expert Panel ldquoEnhancing the Adoption of Comparative Effectiveness Research in the Treatment of Serious Mental Illnesses in Medicaidrdquo

Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services)

4

Technical Expert Panel Member 2010-2011 Schizophrenia Measures Development

Technical Advisory Group Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services) Technical Advisory Group Member

2012-2013 Centers for Medicare and Medicaid Services (CMS) Medicaid Emergency Psychiatric Demonstration Technical Expert Panel

Mathematica Policy Research (project as part of contract with CMS) Technical Expert Panel Member

2012-2013 National Behavior Health Quality Framework Expert Panel

Substance Abuse and Mental Health Services Administration Expert Panel Member

2012-2014 Behavioral Health Measure Development Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation amp Substance Abuse and Mental Health Services Administration Department of Health and Human Services) Technical Advisory Group Member

2014 Technical Brief Outcomes of Serious Mental Illness

Agency for Health Care Research and Quality (AHRQ) Expert Reviewer

2015-2016 Technical Expert Panel Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance

Health Services Advisory Group (project as part of contract with CMS) Technical Expert Panel Member

2016- Quality Committee National Association of Psychiatric Health Systems (NAPHS) Committee Member

Professional Societies 1994- American Psychiatric Association Member 1994-1998 Maryland Psychiatric Society Member 1994-2004 Association of Women Psychiatrists Inc Member 1994-2004 American Medical Association Member 1998- Massachusetts Psychiatric Society Member 1998-2004 American Association of Community Psychiatrists Member 2010-2011 American Medical Informatics Association Member 2016- American Medical Informatics Association Member 2017 Annual Symposium Reviewer 2012- Academy Health 2017 Annual Research Meeting (ARM) Reviewer Behavioral Health Theme

5

Grant Review Activities 2014 R01 Improving Health and Reducing

Premature Mortality in People with Severe Mental Illness

NIMH Ad hoc committee

2015 Mental Health Services Conflicts NIMH June 2015 Special Emphasis Panel 2015 Mental Health Services Conflicts NIMH November 2015 Special Emphasis Panel

Editorial Activities Ad Hoc Reviewer 2003 Social Psychiatry and Psychiatric Epidemiology 2003 Addiction 2004 Biological Psychiatry 2004- Psychiatric Services 2004- Archives of General PsychiatryJAMA Psychiatry 2007- New England Journal of Medicine 2007- Medical Care 2011- Journal of Studies on Alcohol amp Drugs 2011- Journal of Mental Health Policy amp Economics 2012- International Journal of Health Care Quality 2013- American Journal of Psychiatry 2016- Health Services Research

Other Editorial Roles

2005 Special Section Editor Seclusion amp Restraint Psychiatric Services 2005-2006 Special Section Editor Health Services

Research Harvard Review of Psychiatry

Honors and Prizes 1993 Hartford Foundation Clinical Scholar in Geriatric Medicine Johns Hopkins U School of

Medicine 1999 Scholar vanAmeringenAmerican Psychiatric Association Health Services Research

Scholarship Program American Psychiatric Association 2001 Junior Investigator Research Colloquium American Psychiatric Association 2003-2005 Maria Lorenz-Pope Fellowship McLean Hospital 2004-2006 Alcohol Medical Scholar Alcohol Medical Scholars Program 2004 Alfred Pope Award for Young Investigators McLean Hospital 2006 Selected Participant Career Development Institute for Bipolar Disorder 2010 McLean Hospital Vision of Excellence Award 2016 Partners in Excellence Team Award Executive Committee of the Patient Care Assessment

and Quality Improvement Committee McLean Hospital 2016 2016 Partners in Excellence Team Award (team Executive Committee of the Patient Care

Assessment and Quality Improvement Committee of McLean Hospital)

6

Report of Funded and Unfunded Projects Funding Information Past

2000-2005 Price Indexes for Mental Health Treatments NIMH R01 MH62028 (PI Frank) Co-Investigator The principal goal of this research was to develop price index measures for mental health systems that make use of administrative data incorporating learning from clinical research and clinical expertise Our aim was to measure spending (or the price) of treatments associated with an expected level of outcome The research built on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression

2003-2005 Effect of a Carve-Out on Quality of Care for Medicaid Persons Diagnosed with Schizophrenia McLean Hospital Maria Lorenz Pope Fellowship PI ($17391) The purpose of this analysis was to examine the effect of a behavioral health carve-out on quality of care for persons with severe psychiatric disorders

2004-2007 Economic Impacts of New Drugs NIMH R01 MH069721 (PI Frank) Co-Investigator This application proposed a program of research that assesses the net impact of new psychotropic drugs on mental health care spending by examining whether new psychotropic drugs ldquopay for themselvesrdquo by offsetting other mental health care costs We focused on three specific conditions major depression bipolar disorder and schizophrenia Evidence was assessed from clinical trials via the use of meta-analysis The major thrust of the research used data from a large insured population for the years 1991-2000 and from the Florida Medicaid program for the years 1993-2002 An econometric model was specified and estimated using instrumental variables methods to bolster the inferences from the observational data Finally we examined the proposition that offsets occur differentially across racial and ethnic groups for high utilizers and according to the organization of insurance arrangements

2005 Women with Psychiatric Illness At Risk for Losing Child CustodyParental Rights MacArthur Foundation Research Network on Mandated Community Treatment PI ($17397) The principal aim of this research was to examine characteristics of mothers who were in psychiatric treatment and at risk of losing child custody or parental rights

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 2: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

2

Appointments at HospitalsAffiliated Institutions 0700-0809 Psychiatrist-in-Charge Partial Hospital Program Alcohol and Drug Abuse Treatment

Program McLean Hospital 0700-0607 Assistant Psychiatrist McLean Hospital 0707- Associate Psychiatrist McLean Hospital

Other Professional Positions 1991 Ensign US Public Health Service Junior Commissioned Officer Student Training Extern

Program SA-Lantic Community Health Center Hammonton NJ 1997 Administrative Resident The Johns Hopkins Department of Psychiatry and Behavioral

Science Baltimore MD 1998-1999 Emergency Room Psychiatrist Cambridge Hospital Cambridge MA 1999-2001 Consultant in Quality Management Methodology Metropolitan Suburban Area Office

Office of the Area Medical Director Medfield MA 2000-2001 Consultant American Psychiatric Association Washington DC 2001-2003 Member Content Review Board Strategic Institute for Continuing Health Care Education

Strategic Implications International 2004-2005 Consultant RTI International Research Triangle Park NC Major Administrative Leadership Positions Local

2009-2015 Director Integration of Clinical Measurement amp Health Services Research

McLean Hospital

2009-2015 Electronic Medical Record Physician ldquoChampionrdquo (physician leading the implementation but not necessarily someone with informatics experience)

McLean Hospital

2011- Chief Health Services Research Division Partners Psychiatry amp Mental Health Partners HealthCare

2013- eCare Clinical Site ldquoChampionrdquo McLean Hospital 2016- Chief Medical Information Officer McLean Hospital 2016- Director Clinical Performance

Measurement amp Health Services Research McLean Hospital

Committee Service 2007 Bipolar and Psychotic Disorders Evidence

Based Reviews Domain Group McLean Hospital

2008 Strategic Task Force on Information Systems Master Plan

McLean Hospital

2008 Strategic Task Force on Practice-Based Evidence

McLean Hospital

2009-2015 Meditech Steering Committee McLean Hospital 2009- Continuous Quality Improvement

Committee McLean Hospital

2009-2013 Compliance Committee McLean Hospital 2009- Information Technology Steering McLean Hospital

3

Committee 2009- General Executive Committee McLean Hospital 2009-2013 Confidentiality Steering Committee Partners HealthCare 2009-2013 Partners Psychiatry amp Mental Health

Confidentiality Steering Committee Partners Psychiatry amp Mental Health

2009- Executive Committee of the Patient Care Assessment Committee

McLean Hospital

2009- Meditech Computerized Physician Order Entry MD Committee 2009-

McLean Hospital Committee Chair

2009-2011 Compliance Audit Committee 2009-2011

McLean Hospital Committee Chair

2009-2013 Medical Records Committee 2009-2013

McLean Hospital Committee Chair

2010- Clinical Quality Steering Committee Partners Psychiatry amp Mental Health 2010-2015 Committee Member 2016- Committee Co-Chair 2011-2012 Enterprise Medical Record Information

System Steering Committee Partners HealthCare

2013- McLean Hospital eCare Executive Committee

McLean Hospital Co-Chair

2015- eCare Operations Committee McLean Hospital 2013- eCare Research Council Partners HealthCare 2013- eCare Research Council Sub-committees Partners HealthCare 2013-2014 Behavioral Health Assessment 2013-2014 Governance Co-Chair since 2014 2014 Big Data 2013- eCare Privacy Workgroup Partners HealthCare 2014- eCare Clinical Decision Support Committee Partners HealthCare 2014- Partners Psychiatry amp Mental Health

Clinical Decision Support Workgroup Chair

2014- eCare Patient Engagement Committee Partners HealthCare 2014- Research Subcommittee Co-Chair 2014- Suicide Assessment Planning Committee McLean Hospital National and International

2003-2010 Research Network on Mandated Community Treatment 2003-2008 2008-2010

MacArthur Foundation Network Associate Network Member

2009 Committee on the Qualifications of Professionals Providing Mental Health Counseling Services Under TRICARE

Institute of Medicine Committee Member

2010-2012 Technical Expert Panel ldquoEnhancing the Adoption of Comparative Effectiveness Research in the Treatment of Serious Mental Illnesses in Medicaidrdquo

Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services)

4

Technical Expert Panel Member 2010-2011 Schizophrenia Measures Development

Technical Advisory Group Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services) Technical Advisory Group Member

2012-2013 Centers for Medicare and Medicaid Services (CMS) Medicaid Emergency Psychiatric Demonstration Technical Expert Panel

Mathematica Policy Research (project as part of contract with CMS) Technical Expert Panel Member

2012-2013 National Behavior Health Quality Framework Expert Panel

Substance Abuse and Mental Health Services Administration Expert Panel Member

2012-2014 Behavioral Health Measure Development Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation amp Substance Abuse and Mental Health Services Administration Department of Health and Human Services) Technical Advisory Group Member

2014 Technical Brief Outcomes of Serious Mental Illness

Agency for Health Care Research and Quality (AHRQ) Expert Reviewer

2015-2016 Technical Expert Panel Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance

Health Services Advisory Group (project as part of contract with CMS) Technical Expert Panel Member

2016- Quality Committee National Association of Psychiatric Health Systems (NAPHS) Committee Member

Professional Societies 1994- American Psychiatric Association Member 1994-1998 Maryland Psychiatric Society Member 1994-2004 Association of Women Psychiatrists Inc Member 1994-2004 American Medical Association Member 1998- Massachusetts Psychiatric Society Member 1998-2004 American Association of Community Psychiatrists Member 2010-2011 American Medical Informatics Association Member 2016- American Medical Informatics Association Member 2017 Annual Symposium Reviewer 2012- Academy Health 2017 Annual Research Meeting (ARM) Reviewer Behavioral Health Theme

5

Grant Review Activities 2014 R01 Improving Health and Reducing

Premature Mortality in People with Severe Mental Illness

NIMH Ad hoc committee

2015 Mental Health Services Conflicts NIMH June 2015 Special Emphasis Panel 2015 Mental Health Services Conflicts NIMH November 2015 Special Emphasis Panel

Editorial Activities Ad Hoc Reviewer 2003 Social Psychiatry and Psychiatric Epidemiology 2003 Addiction 2004 Biological Psychiatry 2004- Psychiatric Services 2004- Archives of General PsychiatryJAMA Psychiatry 2007- New England Journal of Medicine 2007- Medical Care 2011- Journal of Studies on Alcohol amp Drugs 2011- Journal of Mental Health Policy amp Economics 2012- International Journal of Health Care Quality 2013- American Journal of Psychiatry 2016- Health Services Research

Other Editorial Roles

2005 Special Section Editor Seclusion amp Restraint Psychiatric Services 2005-2006 Special Section Editor Health Services

Research Harvard Review of Psychiatry

Honors and Prizes 1993 Hartford Foundation Clinical Scholar in Geriatric Medicine Johns Hopkins U School of

Medicine 1999 Scholar vanAmeringenAmerican Psychiatric Association Health Services Research

Scholarship Program American Psychiatric Association 2001 Junior Investigator Research Colloquium American Psychiatric Association 2003-2005 Maria Lorenz-Pope Fellowship McLean Hospital 2004-2006 Alcohol Medical Scholar Alcohol Medical Scholars Program 2004 Alfred Pope Award for Young Investigators McLean Hospital 2006 Selected Participant Career Development Institute for Bipolar Disorder 2010 McLean Hospital Vision of Excellence Award 2016 Partners in Excellence Team Award Executive Committee of the Patient Care Assessment

and Quality Improvement Committee McLean Hospital 2016 2016 Partners in Excellence Team Award (team Executive Committee of the Patient Care

Assessment and Quality Improvement Committee of McLean Hospital)

6

Report of Funded and Unfunded Projects Funding Information Past

2000-2005 Price Indexes for Mental Health Treatments NIMH R01 MH62028 (PI Frank) Co-Investigator The principal goal of this research was to develop price index measures for mental health systems that make use of administrative data incorporating learning from clinical research and clinical expertise Our aim was to measure spending (or the price) of treatments associated with an expected level of outcome The research built on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression

2003-2005 Effect of a Carve-Out on Quality of Care for Medicaid Persons Diagnosed with Schizophrenia McLean Hospital Maria Lorenz Pope Fellowship PI ($17391) The purpose of this analysis was to examine the effect of a behavioral health carve-out on quality of care for persons with severe psychiatric disorders

2004-2007 Economic Impacts of New Drugs NIMH R01 MH069721 (PI Frank) Co-Investigator This application proposed a program of research that assesses the net impact of new psychotropic drugs on mental health care spending by examining whether new psychotropic drugs ldquopay for themselvesrdquo by offsetting other mental health care costs We focused on three specific conditions major depression bipolar disorder and schizophrenia Evidence was assessed from clinical trials via the use of meta-analysis The major thrust of the research used data from a large insured population for the years 1991-2000 and from the Florida Medicaid program for the years 1993-2002 An econometric model was specified and estimated using instrumental variables methods to bolster the inferences from the observational data Finally we examined the proposition that offsets occur differentially across racial and ethnic groups for high utilizers and according to the organization of insurance arrangements

2005 Women with Psychiatric Illness At Risk for Losing Child CustodyParental Rights MacArthur Foundation Research Network on Mandated Community Treatment PI ($17397) The principal aim of this research was to examine characteristics of mothers who were in psychiatric treatment and at risk of losing child custody or parental rights

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 3: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

3

Committee 2009- General Executive Committee McLean Hospital 2009-2013 Confidentiality Steering Committee Partners HealthCare 2009-2013 Partners Psychiatry amp Mental Health

Confidentiality Steering Committee Partners Psychiatry amp Mental Health

2009- Executive Committee of the Patient Care Assessment Committee

McLean Hospital

2009- Meditech Computerized Physician Order Entry MD Committee 2009-

McLean Hospital Committee Chair

2009-2011 Compliance Audit Committee 2009-2011

McLean Hospital Committee Chair

2009-2013 Medical Records Committee 2009-2013

McLean Hospital Committee Chair

2010- Clinical Quality Steering Committee Partners Psychiatry amp Mental Health 2010-2015 Committee Member 2016- Committee Co-Chair 2011-2012 Enterprise Medical Record Information

System Steering Committee Partners HealthCare

2013- McLean Hospital eCare Executive Committee

McLean Hospital Co-Chair

2015- eCare Operations Committee McLean Hospital 2013- eCare Research Council Partners HealthCare 2013- eCare Research Council Sub-committees Partners HealthCare 2013-2014 Behavioral Health Assessment 2013-2014 Governance Co-Chair since 2014 2014 Big Data 2013- eCare Privacy Workgroup Partners HealthCare 2014- eCare Clinical Decision Support Committee Partners HealthCare 2014- Partners Psychiatry amp Mental Health

Clinical Decision Support Workgroup Chair

2014- eCare Patient Engagement Committee Partners HealthCare 2014- Research Subcommittee Co-Chair 2014- Suicide Assessment Planning Committee McLean Hospital National and International

2003-2010 Research Network on Mandated Community Treatment 2003-2008 2008-2010

MacArthur Foundation Network Associate Network Member

2009 Committee on the Qualifications of Professionals Providing Mental Health Counseling Services Under TRICARE

Institute of Medicine Committee Member

2010-2012 Technical Expert Panel ldquoEnhancing the Adoption of Comparative Effectiveness Research in the Treatment of Serious Mental Illnesses in Medicaidrdquo

Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services)

4

Technical Expert Panel Member 2010-2011 Schizophrenia Measures Development

Technical Advisory Group Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services) Technical Advisory Group Member

2012-2013 Centers for Medicare and Medicaid Services (CMS) Medicaid Emergency Psychiatric Demonstration Technical Expert Panel

Mathematica Policy Research (project as part of contract with CMS) Technical Expert Panel Member

2012-2013 National Behavior Health Quality Framework Expert Panel

Substance Abuse and Mental Health Services Administration Expert Panel Member

2012-2014 Behavioral Health Measure Development Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation amp Substance Abuse and Mental Health Services Administration Department of Health and Human Services) Technical Advisory Group Member

2014 Technical Brief Outcomes of Serious Mental Illness

Agency for Health Care Research and Quality (AHRQ) Expert Reviewer

2015-2016 Technical Expert Panel Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance

Health Services Advisory Group (project as part of contract with CMS) Technical Expert Panel Member

2016- Quality Committee National Association of Psychiatric Health Systems (NAPHS) Committee Member

Professional Societies 1994- American Psychiatric Association Member 1994-1998 Maryland Psychiatric Society Member 1994-2004 Association of Women Psychiatrists Inc Member 1994-2004 American Medical Association Member 1998- Massachusetts Psychiatric Society Member 1998-2004 American Association of Community Psychiatrists Member 2010-2011 American Medical Informatics Association Member 2016- American Medical Informatics Association Member 2017 Annual Symposium Reviewer 2012- Academy Health 2017 Annual Research Meeting (ARM) Reviewer Behavioral Health Theme

5

Grant Review Activities 2014 R01 Improving Health and Reducing

Premature Mortality in People with Severe Mental Illness

NIMH Ad hoc committee

2015 Mental Health Services Conflicts NIMH June 2015 Special Emphasis Panel 2015 Mental Health Services Conflicts NIMH November 2015 Special Emphasis Panel

Editorial Activities Ad Hoc Reviewer 2003 Social Psychiatry and Psychiatric Epidemiology 2003 Addiction 2004 Biological Psychiatry 2004- Psychiatric Services 2004- Archives of General PsychiatryJAMA Psychiatry 2007- New England Journal of Medicine 2007- Medical Care 2011- Journal of Studies on Alcohol amp Drugs 2011- Journal of Mental Health Policy amp Economics 2012- International Journal of Health Care Quality 2013- American Journal of Psychiatry 2016- Health Services Research

Other Editorial Roles

2005 Special Section Editor Seclusion amp Restraint Psychiatric Services 2005-2006 Special Section Editor Health Services

Research Harvard Review of Psychiatry

Honors and Prizes 1993 Hartford Foundation Clinical Scholar in Geriatric Medicine Johns Hopkins U School of

Medicine 1999 Scholar vanAmeringenAmerican Psychiatric Association Health Services Research

Scholarship Program American Psychiatric Association 2001 Junior Investigator Research Colloquium American Psychiatric Association 2003-2005 Maria Lorenz-Pope Fellowship McLean Hospital 2004-2006 Alcohol Medical Scholar Alcohol Medical Scholars Program 2004 Alfred Pope Award for Young Investigators McLean Hospital 2006 Selected Participant Career Development Institute for Bipolar Disorder 2010 McLean Hospital Vision of Excellence Award 2016 Partners in Excellence Team Award Executive Committee of the Patient Care Assessment

and Quality Improvement Committee McLean Hospital 2016 2016 Partners in Excellence Team Award (team Executive Committee of the Patient Care

Assessment and Quality Improvement Committee of McLean Hospital)

6

Report of Funded and Unfunded Projects Funding Information Past

2000-2005 Price Indexes for Mental Health Treatments NIMH R01 MH62028 (PI Frank) Co-Investigator The principal goal of this research was to develop price index measures for mental health systems that make use of administrative data incorporating learning from clinical research and clinical expertise Our aim was to measure spending (or the price) of treatments associated with an expected level of outcome The research built on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression

2003-2005 Effect of a Carve-Out on Quality of Care for Medicaid Persons Diagnosed with Schizophrenia McLean Hospital Maria Lorenz Pope Fellowship PI ($17391) The purpose of this analysis was to examine the effect of a behavioral health carve-out on quality of care for persons with severe psychiatric disorders

2004-2007 Economic Impacts of New Drugs NIMH R01 MH069721 (PI Frank) Co-Investigator This application proposed a program of research that assesses the net impact of new psychotropic drugs on mental health care spending by examining whether new psychotropic drugs ldquopay for themselvesrdquo by offsetting other mental health care costs We focused on three specific conditions major depression bipolar disorder and schizophrenia Evidence was assessed from clinical trials via the use of meta-analysis The major thrust of the research used data from a large insured population for the years 1991-2000 and from the Florida Medicaid program for the years 1993-2002 An econometric model was specified and estimated using instrumental variables methods to bolster the inferences from the observational data Finally we examined the proposition that offsets occur differentially across racial and ethnic groups for high utilizers and according to the organization of insurance arrangements

2005 Women with Psychiatric Illness At Risk for Losing Child CustodyParental Rights MacArthur Foundation Research Network on Mandated Community Treatment PI ($17397) The principal aim of this research was to examine characteristics of mothers who were in psychiatric treatment and at risk of losing child custody or parental rights

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 4: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

4

Technical Expert Panel Member 2010-2011 Schizophrenia Measures Development

Technical Advisory Group Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation Department of Health and Human Services) Technical Advisory Group Member

2012-2013 Centers for Medicare and Medicaid Services (CMS) Medicaid Emergency Psychiatric Demonstration Technical Expert Panel

Mathematica Policy Research (project as part of contract with CMS) Technical Expert Panel Member

2012-2013 National Behavior Health Quality Framework Expert Panel

Substance Abuse and Mental Health Services Administration Expert Panel Member

2012-2014 Behavioral Health Measure Development Mathematica Policy Research (project as part of contract with Office for the Assistant Secretary for Planning and Evaluation amp Substance Abuse and Mental Health Services Administration Department of Health and Human Services) Technical Advisory Group Member

2014 Technical Brief Outcomes of Serious Mental Illness

Agency for Health Care Research and Quality (AHRQ) Expert Reviewer

2015-2016 Technical Expert Panel Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance

Health Services Advisory Group (project as part of contract with CMS) Technical Expert Panel Member

2016- Quality Committee National Association of Psychiatric Health Systems (NAPHS) Committee Member

Professional Societies 1994- American Psychiatric Association Member 1994-1998 Maryland Psychiatric Society Member 1994-2004 Association of Women Psychiatrists Inc Member 1994-2004 American Medical Association Member 1998- Massachusetts Psychiatric Society Member 1998-2004 American Association of Community Psychiatrists Member 2010-2011 American Medical Informatics Association Member 2016- American Medical Informatics Association Member 2017 Annual Symposium Reviewer 2012- Academy Health 2017 Annual Research Meeting (ARM) Reviewer Behavioral Health Theme

5

Grant Review Activities 2014 R01 Improving Health and Reducing

Premature Mortality in People with Severe Mental Illness

NIMH Ad hoc committee

2015 Mental Health Services Conflicts NIMH June 2015 Special Emphasis Panel 2015 Mental Health Services Conflicts NIMH November 2015 Special Emphasis Panel

Editorial Activities Ad Hoc Reviewer 2003 Social Psychiatry and Psychiatric Epidemiology 2003 Addiction 2004 Biological Psychiatry 2004- Psychiatric Services 2004- Archives of General PsychiatryJAMA Psychiatry 2007- New England Journal of Medicine 2007- Medical Care 2011- Journal of Studies on Alcohol amp Drugs 2011- Journal of Mental Health Policy amp Economics 2012- International Journal of Health Care Quality 2013- American Journal of Psychiatry 2016- Health Services Research

Other Editorial Roles

2005 Special Section Editor Seclusion amp Restraint Psychiatric Services 2005-2006 Special Section Editor Health Services

Research Harvard Review of Psychiatry

Honors and Prizes 1993 Hartford Foundation Clinical Scholar in Geriatric Medicine Johns Hopkins U School of

Medicine 1999 Scholar vanAmeringenAmerican Psychiatric Association Health Services Research

Scholarship Program American Psychiatric Association 2001 Junior Investigator Research Colloquium American Psychiatric Association 2003-2005 Maria Lorenz-Pope Fellowship McLean Hospital 2004-2006 Alcohol Medical Scholar Alcohol Medical Scholars Program 2004 Alfred Pope Award for Young Investigators McLean Hospital 2006 Selected Participant Career Development Institute for Bipolar Disorder 2010 McLean Hospital Vision of Excellence Award 2016 Partners in Excellence Team Award Executive Committee of the Patient Care Assessment

and Quality Improvement Committee McLean Hospital 2016 2016 Partners in Excellence Team Award (team Executive Committee of the Patient Care

Assessment and Quality Improvement Committee of McLean Hospital)

6

Report of Funded and Unfunded Projects Funding Information Past

2000-2005 Price Indexes for Mental Health Treatments NIMH R01 MH62028 (PI Frank) Co-Investigator The principal goal of this research was to develop price index measures for mental health systems that make use of administrative data incorporating learning from clinical research and clinical expertise Our aim was to measure spending (or the price) of treatments associated with an expected level of outcome The research built on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression

2003-2005 Effect of a Carve-Out on Quality of Care for Medicaid Persons Diagnosed with Schizophrenia McLean Hospital Maria Lorenz Pope Fellowship PI ($17391) The purpose of this analysis was to examine the effect of a behavioral health carve-out on quality of care for persons with severe psychiatric disorders

2004-2007 Economic Impacts of New Drugs NIMH R01 MH069721 (PI Frank) Co-Investigator This application proposed a program of research that assesses the net impact of new psychotropic drugs on mental health care spending by examining whether new psychotropic drugs ldquopay for themselvesrdquo by offsetting other mental health care costs We focused on three specific conditions major depression bipolar disorder and schizophrenia Evidence was assessed from clinical trials via the use of meta-analysis The major thrust of the research used data from a large insured population for the years 1991-2000 and from the Florida Medicaid program for the years 1993-2002 An econometric model was specified and estimated using instrumental variables methods to bolster the inferences from the observational data Finally we examined the proposition that offsets occur differentially across racial and ethnic groups for high utilizers and according to the organization of insurance arrangements

2005 Women with Psychiatric Illness At Risk for Losing Child CustodyParental Rights MacArthur Foundation Research Network on Mandated Community Treatment PI ($17397) The principal aim of this research was to examine characteristics of mothers who were in psychiatric treatment and at risk of losing child custody or parental rights

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 5: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

5

Grant Review Activities 2014 R01 Improving Health and Reducing

Premature Mortality in People with Severe Mental Illness

NIMH Ad hoc committee

2015 Mental Health Services Conflicts NIMH June 2015 Special Emphasis Panel 2015 Mental Health Services Conflicts NIMH November 2015 Special Emphasis Panel

Editorial Activities Ad Hoc Reviewer 2003 Social Psychiatry and Psychiatric Epidemiology 2003 Addiction 2004 Biological Psychiatry 2004- Psychiatric Services 2004- Archives of General PsychiatryJAMA Psychiatry 2007- New England Journal of Medicine 2007- Medical Care 2011- Journal of Studies on Alcohol amp Drugs 2011- Journal of Mental Health Policy amp Economics 2012- International Journal of Health Care Quality 2013- American Journal of Psychiatry 2016- Health Services Research

Other Editorial Roles

2005 Special Section Editor Seclusion amp Restraint Psychiatric Services 2005-2006 Special Section Editor Health Services

Research Harvard Review of Psychiatry

Honors and Prizes 1993 Hartford Foundation Clinical Scholar in Geriatric Medicine Johns Hopkins U School of

Medicine 1999 Scholar vanAmeringenAmerican Psychiatric Association Health Services Research

Scholarship Program American Psychiatric Association 2001 Junior Investigator Research Colloquium American Psychiatric Association 2003-2005 Maria Lorenz-Pope Fellowship McLean Hospital 2004-2006 Alcohol Medical Scholar Alcohol Medical Scholars Program 2004 Alfred Pope Award for Young Investigators McLean Hospital 2006 Selected Participant Career Development Institute for Bipolar Disorder 2010 McLean Hospital Vision of Excellence Award 2016 Partners in Excellence Team Award Executive Committee of the Patient Care Assessment

and Quality Improvement Committee McLean Hospital 2016 2016 Partners in Excellence Team Award (team Executive Committee of the Patient Care

Assessment and Quality Improvement Committee of McLean Hospital)

6

Report of Funded and Unfunded Projects Funding Information Past

2000-2005 Price Indexes for Mental Health Treatments NIMH R01 MH62028 (PI Frank) Co-Investigator The principal goal of this research was to develop price index measures for mental health systems that make use of administrative data incorporating learning from clinical research and clinical expertise Our aim was to measure spending (or the price) of treatments associated with an expected level of outcome The research built on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression

2003-2005 Effect of a Carve-Out on Quality of Care for Medicaid Persons Diagnosed with Schizophrenia McLean Hospital Maria Lorenz Pope Fellowship PI ($17391) The purpose of this analysis was to examine the effect of a behavioral health carve-out on quality of care for persons with severe psychiatric disorders

2004-2007 Economic Impacts of New Drugs NIMH R01 MH069721 (PI Frank) Co-Investigator This application proposed a program of research that assesses the net impact of new psychotropic drugs on mental health care spending by examining whether new psychotropic drugs ldquopay for themselvesrdquo by offsetting other mental health care costs We focused on three specific conditions major depression bipolar disorder and schizophrenia Evidence was assessed from clinical trials via the use of meta-analysis The major thrust of the research used data from a large insured population for the years 1991-2000 and from the Florida Medicaid program for the years 1993-2002 An econometric model was specified and estimated using instrumental variables methods to bolster the inferences from the observational data Finally we examined the proposition that offsets occur differentially across racial and ethnic groups for high utilizers and according to the organization of insurance arrangements

2005 Women with Psychiatric Illness At Risk for Losing Child CustodyParental Rights MacArthur Foundation Research Network on Mandated Community Treatment PI ($17397) The principal aim of this research was to examine characteristics of mothers who were in psychiatric treatment and at risk of losing child custody or parental rights

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 6: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

6

Report of Funded and Unfunded Projects Funding Information Past

2000-2005 Price Indexes for Mental Health Treatments NIMH R01 MH62028 (PI Frank) Co-Investigator The principal goal of this research was to develop price index measures for mental health systems that make use of administrative data incorporating learning from clinical research and clinical expertise Our aim was to measure spending (or the price) of treatments associated with an expected level of outcome The research built on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression

2003-2005 Effect of a Carve-Out on Quality of Care for Medicaid Persons Diagnosed with Schizophrenia McLean Hospital Maria Lorenz Pope Fellowship PI ($17391) The purpose of this analysis was to examine the effect of a behavioral health carve-out on quality of care for persons with severe psychiatric disorders

2004-2007 Economic Impacts of New Drugs NIMH R01 MH069721 (PI Frank) Co-Investigator This application proposed a program of research that assesses the net impact of new psychotropic drugs on mental health care spending by examining whether new psychotropic drugs ldquopay for themselvesrdquo by offsetting other mental health care costs We focused on three specific conditions major depression bipolar disorder and schizophrenia Evidence was assessed from clinical trials via the use of meta-analysis The major thrust of the research used data from a large insured population for the years 1991-2000 and from the Florida Medicaid program for the years 1993-2002 An econometric model was specified and estimated using instrumental variables methods to bolster the inferences from the observational data Finally we examined the proposition that offsets occur differentially across racial and ethnic groups for high utilizers and according to the organization of insurance arrangements

2005 Women with Psychiatric Illness At Risk for Losing Child CustodyParental Rights MacArthur Foundation Research Network on Mandated Community Treatment PI ($17397) The principal aim of this research was to examine characteristics of mothers who were in psychiatric treatment and at risk of losing child custody or parental rights

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 7: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

7

2005-2008 Modeling Treatment Use amp Effectiveness in Mental Illness NIMH R01 MH061434 (PI Normand) Co-Investigator This application sought continued support for a team of statisticians economists and clinicians to collaborate on the development and application of longitudinal hierarchical discrete choice models for understanding diffusion of mental health technologies and for causal inference

2005-2011 Quality of Care for Bipolar Disorder NIMH K01 MH071714 PI ($834662) This Mentored Career Development Award examined patient provider treatment and organizationalfinancing characteristics associated with outcomes in both a national multi-site clinical effectiveness trial for bipolar disorder and a usual care private insurance administrative dataset

2008-2012 Effects of Mental Health Parity on High-Cost and Severely-Ill Individuals NIMH R01MH080797 (PI Huskamp) Site-PI ($6978) Mental health parity policies aim to protect individuals with severe mental illnesses against the catastrophic costs of seeking treatment and in doing so increase efficiency and fairness in the insurance market In 2001 all plans participating in the Federal Employees Health Benefits (FEHB) Program were required to offer coverage for MHSA services on a par with general medical services This stud 1) assessed whether individuals with high MHSA expenditures disproportionately benefited from the comprehensive FEHB parity policy 2) compared characteristics of high spenders before and after parity adoption and 3) examined how parity affected the composition intensity and quality of treatment received

2010-2013 Accounting for Confounding Bias and Treatment Heterogeneity in Comparative Effectiveness Research NIMH RC4 MH092717 (PI OrsquoMalley) Site-PI ($59839) This research developed novel and generalizable statistical methods for addressing the limitations of currently available comparative effectiveness data We applied these methods to three important clinical examples treatments for bipolar disorder in patients with psychiatric co-morbidity reformulations of existing psychiatric drug treatments and surgical repair for abdominal aortic aneurysm (AAA)

2008-2013 Mental Health Spending and Quality of Care NIMH R01 MH081819 (PI Frank) Co-Investigator Policy makers must understand empirical trade-offs between mental health spending levels of treatment and quality of care Measurement technology for costs needs and quality is imperfect but can nonetheless contribute to good decisions As is clear from the recent Institute of Medicine (IOM) report on Performance Measurement Accelerating Improvement (2005) there will be no complete quality measurement system in the foreseeable future but there is progress and policy must work with the available and improving measures in the interim We used existing measures of quality and case mix to

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 8: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

8

make progress on understanding the interrelations between spending quality and treatment

12012010-11302015

Medicare Drug Benefits and High Cost Medications Antipsychotics Under Part D NIMH R01 MH090284 (PI Fung) Site-PI ($28716) In 2006 Medicare introduced Part D outpatient prescription drug benefits which could have significant implications for patients requiring chronic and high cost drug therapy such as antipsychotics This study examined the impact of Part D coverage on 1) drug use and adherence 2) adverse clinical events including emergency department visits hospitalizations and death and 3) medical spending including out-of pocket drug spending and pharmacy outpatient inpatient and total medical costs

093013-103116

An Examination of Behavioral Healthcare Integration in Medicare Accountable Care Organizations DHHSOffice for the Asst Secretary for Planning and Evaluation (ASPE) HHSP23320130051C (PI McWilliams) Co-Investigator Using both quantitative and qualitative methods this project will examine the impact of Accountable Care Organizations (ACOs) in Medicare on behavioral health care and outcomes and explore the extent to which ACOs target behavioral health conditions for value-enhancing changes in care management

Current

10012011-

Partners Psychiatry amp Mental HealthHealth Services Research Division ChiefPI ($170000) The goal of this research is to conduct services research pertinent to Partners Psychiatry regarding patient characteristics associated with high cost service utilization in an effort to determine how to improve the quality and efficiency of mental health care within the organization

07012015-06302020

Center to Improve System Performance of Substance Use Disorder (SUD) Treatment NIDA P30 DA035772-01A1 (PI Horgan) Site Co-PI ($717654) The Centerrsquos goal is to use research on payment methods and service delivery approaches to synergistically expand the research base to ensure that SUD treatment services are included in efforts to improve quality and reduce the cost of health care services and to inform policy decisions that will profoundly affect the cost quality and availability of SUD treatment services

10012015-09302018

Impact of High Deductible Health Plans on Patients with Bipolar Disorder Patient-Centered Outcomes Research Institute (PCORI) HIS-1408-20393 (PI LuWharam) Site-PI ($85616) The goal of this study is to determine the effects of High Deductible Health Plans (HDHPs) on patients with bipolar disorder on healthcare utilization quality of care clinical outcomes and health disparities We will also assess patient experiences coping with complex insurance benefits and contrast patient views on higher- and lower-value care and standard definitions and concepts of ldquohealthcare valuerdquo

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 9: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

9

1212016-113017

Improving Quality While Managing Cost for Youth Mental Health Judge Baker Childrenrsquos Center (PI Cheron) Subcontract-PI ($180000) This study will use administrative data to examine the effect of a novel modular psychotherapy on utilization and costs for ambulatory mental health care for youth (ages 6-15) with depression anxiety and conduct disorders

Report of Local Teaching and Training

Teaching of Students in Courses 2003-2008 Patient-Doctor Course I McLean Hospital 1st year medical students 1 hour session per year 2006-2009 Psychopathology and Introduction to

Clinical Psychiatry Harvard Medical School

1st year medical students 1 hour session twice a year

Formal Teaching of Residents Clinical Fellows and Research Fellows (post-docs) 2001-2005 Addiction Psychiatry Consultation Service McLean Hospital 4 hours per year 2005-2009 Didactic patient interviewing seminar for

PGY-III residents McLean Hospital

4 hours per year 2007-2009 Didactic patient-interview teaching seminar

of PGY-I interns on the inpatient detoxification service

McLean Hospital

1 hour per week 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-4 Journal Club

McLean Hospital

April 2014 2014 Massachusetts General HospitalMcLean

Hospital Psychiatry Residency Program PGY-3 Community Psychiatry Rotation Didactic Seminar

Massachusetts General Hospital

August 2014 Clinical Supervisory and Training Responsibilities

2005-2009 Supervision of addiction fellowAlcohol and Drug Abuse Partial Hospital Treatment Program McLean Hospital

McLean Hospital

Weekly supervision for 2 months each year

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 10: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

10

Formally Supervised Trainees

2006-2011 Cathy Fullerton MD MPH Research Leader at Truven Health Analytics Supervision in conducting mental health services research 2 publications Medical Care and Archives of General Psychiatry (publications 19 and 25 below)

2010-2012 Benjamin Herbstman MD Instructor in Psychiatry Tutorialsupervision in mental health policy and services research

2009-2010 Katy Backes Kozhimanil PhDAssociate Professor Division of Health Policy and Management University of Minnesota School of Public Health Mentored Dr Kozhimanil while she was a doctoral candidate regarding mental health services research as part of completion of research using claims data to study changes in screening for and quality of post-partum depression care for Medicaid women in NJ after the state implemented a new policy for post-partum depression screening (publications 21 and 23 below)

2010-2012 Stacey Dusetzina PhDResearch Assistant Professor in Health Policy and Management and Medicine University of North Carolina at Chapel Hill Gillings School of Global Public Health Mentored post-doctoral fellow in mental health services research in completion of several research papers using claims data to study prescribing patterns of antipsychotic medications (publications 28 and 30 below)

2011-2012 Ivy Zang RN McLean Hospital Mentored RN in a quality assessment project that aimed to better characterize the frequency and type of aggressive behaviors on inpatient psychiatric units

2011- Kathryn Boger Dingman PhDProgram Director McLean Anxiety Mastery Program Instructor in Psychology in the Department of Psychiatry McLean Hospital Supervision of research project (prospective observational study of adolescents in residential treatment for substance use disorders) as part of a McLean Hospital research fellowship (publication 36 below) Her fellowship is complete and we continue with career mentoringadvisement

2012-2013 John Palmieri MDMedical Director North Suffolk Mental Health Supervision of research project (observational study of claims data to examine patterns of ED use in ED high utilizers)

2013-2014 Courtney Beard Elias PhDClinical and Research Psychologist Instructor in Psychiatry Part-Time Behavioral Health Partial Hospital Program McLean Hospital Supervision of research project (observational study of patient reported outcomes data from the Clinical Measurement Initiative (CMI) and McLeanrsquos Behavioral Health Partial Hospital Program) that examined patient characteristics associated with inpatient hospitalization during partial hospital level of care (publication 42 below)

2013-2014 Bridget Hearon PhDAdjunct Faculty Mental Health Counseling and Behavioral Medicine Program Boston University School of Medicine Supervision of research project examining the accuracy of a single-item drug screening instrument in a psychiatrically ill partial-hospital population compared with a structured clinical interview and 10-item screening instrument This study used CMI data in part and was published in the Journal of Substance Abuse Treatment in February 2015 (publication

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 11: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

11

37 below)

2012- Thomas Weigel MDAssociate Director Klarman Eating Disorder Center Instructor in Psychiatry McLean Hospital Supervision of junior faculty member in health services research on eating disorder outcomes Current research project is examining whether there are different eating disorder outcomes for Klarman patients who screen positive for borderline personality disorder substance use disorder both or neither of these co-morbidities Poster of preliminary findings presented McLean Hospital 2015 Research Day Manuscript submitted for review

2013-2014 Maya Reddy LICSWClinical Social Worker McLean Hospital Supervision of research project examining the accuracy of inpatient case managers in predicting 30-day readmission and completion of community follow-up within 7 days of discharge Poster of findings presented at McLean Hospital 2015 Research Day Manuscript was recently accepted for publication in Psychiatric Services (publication 41 below)

2014-2017 Nicole Kozloff MD MS student Harvard TH Chan School of Public Health Dr Kozloff is a Canadian childadolescent psychiatry resident with interests in mental health policy and services research She approached me in the Fall of 2014 for mentoring in this field Initially our discussions focused on mentoring in choosing a mental health policy and services research fellowship Fall 2015 she matriculated to the Harvard School of Public Health to earn an MS in Health Policy and Management as part of an overall program of study for her Canadian fellowship She completed her degree December 2016 and returns to Canada in the fall 2017 Our discussions have centered on structuring her fellowship to ensure that she receives the didactic and research experience that will form the foundation for her clinical research career

2014- Nicole Benson MDPGY-3 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision of research project examining predictors of clinical outcomes of transitional age youth who receive ECT This study uses data from the CMI It was accepted for presentation on August 3 2016 at the NIMH New Investigators Workshop which was held in conjunction with the 23rd NIMH Conference on Mental Health Services Research It has also been accepted as an invited abstract oral presentation at the 2017 American Psychiatric Association Annual meeting and poster at McLean Hospital Research Day on January 18 2017

2015- Jessica Becker MD PGY-2 MGH-McLean Psychiatry ResidentResearch Track Mentoringsupervision in mental health services research

Formal Teaching of Peers (eg CME and other continuing education courses)

2004 Substance Use Disorders Psychiatry 2004 McLean Hospital

Single presentation Cambridge MA

2008 Substance Use Disorders Diagnosis and Treatment National Association of Social Workers Massachusetts Chapter

Single presentation Belmont MA

2008 Community Treatment of Bipolar Depression Service Single presentation

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 12: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

12

Utilization and Quality American Psychiatric Association Annual Meeting

Washington DC

Report of Regional National and International Invited Teaching and Presentations Local No presentations below were sponsored by outside entities

May 19 2011

The Clinical Measurement Initiative at McLean Hospital McLean Hospital Board of Trustees and Board Sub-Committee on Quality

October 20 2011

The McLean Hospital Clinical Measurement Initiative Using Computerized Patient Self-Assessment to Monitor and Improve Patient Care McLean Hospital National Council Meeting

January 30 2012

Monitoring Mental Health Patient Outcomes Through REDCap The Clinical Measurement Initiative at McLean Hospital Brigham amp WomenrsquosFaulkner Hospitals Clinical Initiatives Meeting

February 23 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter McLean Hospital Grand Rounds

December 6 2012

Informing Patient Care and Measuring Outcomes The Clinical Measurement Initiative at McLean Hospital McLean Hospital Grand Rounds

November 12 2015

Partners Patient Reported Outcomes Measurement (PROMs) Summit Partners HealthCare Population Health ManagementQuality Safety and Value ndash PROMs

March 3 2016

Early Effects of Medicare Accountable Care Organization (ACO) Programs on Mental Health Care Spending and Quality McLean Hospital Grand Rounds

February 9 2017

Electronic Health Records in Psychiatric Care McLean Hospital Grand Rounds

National The presentation below sponsored by an outside entity is so noted and the sponsor is identified

October 29 2003

Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Schizophrenia (invited presentation) Florida Mental Health Institute University of South Florida Tampa FL

June 24 2004

Schizophrenia Co-Occurring Substance Use Disorders and Quality in a Behavioral Health Carve-Out (selected oral abstract) Conference of Co-Occurring Disorders (NIMH NIDA NIAA SAMHSA) Washington DC

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 13: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

13

November 6 2006

Impact of Parity on the Quality of Care for Major Depression (selected oral abstract) American Public Health Association Boston MA

June 8 2008

Whats Behind the Explosion amp Use of Psychotropic Medication (invited discussant) Academy Health Annual Research Meeting Washington DC

July 27 2011

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) NIMH Health Services Research Conference Washington DC

May 29 2012

How Similar are Patients Who Participate in Randomized Controlled Trials from Those Who Do Not (selected oral abstract) New Research Approaches to Mental Health Interventions (NCDEU) Phoenix AZ

June 24 2012

The Effect of Parity on Behavioral Health Utilization amp Costs Does Diagnostic Severity Matter (selected oral abstract) Academy Health Annual Conference Orlando FL

October 17 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Co-morbidity and Local Health Care Systems (selected oral abstract) Addictions Health Services Research Conference Boston MA

May 17 2015

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) American Psychiatric Association Annual Meeting Toronto ON Canada

December 11 2015

Performance Measures for the Treatment of Substance Use Disorders Opportunities for the CTN NIDA Clinical Trials Network (CTN) Data Science Task Force Webinar (invited presentation)

May16 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality American Psychiatric Association Annual Meeting (selected oral abstract) Atlanta GA

June 27 2016

Early Effects of Medicare ACO Programs on Mental Healthcare Spending and Quality (selected oral abstract) Academy Health Annual Research Meeting Boston MA

September 20 2016

Addressing the Opioid Crisis Whatrsquos Next (invited panelist for congressional staff briefing) Dirksen Senate Office Building Washington DC (sponsored by the American Hospital Association and The Partnership to Amend 42 CFR Part 2)

November 14 2016

Mental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make It All Work (selected oral abstract) American Medical Informatics Association Annual Symposium

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 14: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

14

Chicago IL

May 20 2017

Prescribing Second-Generation Antipsychotic Medications of Higher Versus Lower Metabolic Risk The Role of Patient Characteristics (selected oral abstract) American Psychiatric Association Annual Meeting San Diego CA

International No presentations below were sponsored by outside entities

September 27 2014

Thirty Day Hospital Readmission for Medicaid Enrollees with Schizophrenia The Role of Patient Characteristics and Local Health Care Systems (selected oral abstract) Second Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health International Center for Mental Health Policy and Economics Washington DC

September 24 2016

Implementing Electronic Patient Reported Outcomes Measurement (ePROMS) in Usual Care Psychiatric Settings (selected oral abstract) Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health - Outcomes In Mental and Addictive Disorders Personal Clinical and Social Perspectives International Center for Mental Health Policy and Economics Washington DC

Report of Clinical Activities and Innovations Current Licensure and Certification 1996 Maryland Medical License currently inactive status 1998 Massachusetts Controlled Substance Practitioner Registration 1998 Massachusetts Medical License 1999 National Board of Psychiatry and Neurology Board Certification 1999 DEA Controlled Substance Registration Certificate 2004 Center for Substance Abuse Treatment Opioid Maintenance and Detoxification Waiver

Certification 2017 American Board of Preventive Medicine Clinical Informatics Board Certification Practice Activities

1998-1999

Emergency Psychiatry Psychiatric Emergency Service Cambridge Hospital

8 hours per week

1999-2000

Per diem psychiatry coverage Multiple regional hospital locations

2 shifts per month

2000-2009

Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

8 hour per week

2015- Partial Hospital Program attending psychiatrist

Alcohol and Drug Abuse Treatment Program McLean Hospital

4 hours per week

Clinical Innovations

An overarching theme of my contribution to clinical innovation is the development implementation and

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 15: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

15

use of electronic infrastructure programs to improve patient care population outcomes assessment and research In recognition of my clinical innovations in implementing and optimizing electronic clinical systems at McLean in January 2016 I became McLean Hospitalrsquos first Chief Medical Information Officer In December 2016 I became a diplomate of the American Board of Preventive Medicinersquos Board Certification in Clinical Informatics this clinical subspecialty certification is effective as of January 2017 Below I detail my contributions in clinical informatics applied to psychiatric care

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present)

Since 2009 my hospital responsibilities have included the implementation and ongoing optimization of our first electronic medical record Meditech Now my responsibilities are transitioning to implementing Partners eCare (Epic) at McLean which is planned for June 2017 My specific contributions are

Meditech Physician Champion Direct process improvement for clinical workflows and safety including consideration of how the electronic medical record can improve patient care and safety via clinical decision support and other mechanisms at McLean Examples include prescribing and monitoring for higher risk medications such as warfarin and lithium metabolic monitoring tobacco screening and treatment and urine toxicology screening

eCare McLean Site Clinician Champion McLean is a free-standing psychiatric hospital with some clinical workflows levels of care and regulatory requirements that are distinct from psychiatric care in general medical hospitals Since 2011 I have been McLean Hospitalrsquos eCare Clinician Site Champion In this role I have organized McLeanrsquos clinical participation in the broader Partners eCare build for psychiatry and have represented McLean-specific needs in eCare throughout Partners In the process of my eCare work I have contributed to the development of eCare tools that will facilitate and improve psychiatric care more generally across Partners For example

bull I am a member of the Partners eCare Clinical Decision Support Committee and lead the subcommittee for Partners Psychiatry and Mental Health In this subcommittee we prioritized psychiatric-specific clinical decision support needs and submitted them to the larger eCare Clinical Decision Support Committee all of which were approved I then worked closely with the eCare informaticists to develop the specifications for these approved clinical decision supports Examples of approved requests are lithium and clozapine monitoring metabolic syndrome monitoring screening for substance use disorders and facilitation of several other regulatory processes required in psychiatry

bull I was a member of the eCare Behavioral Health Assessment subcommittee a Partners Psychiatry and Mental Health committee of clinical researchers We derived a consensus for which patient self-reported outcome measuressurveys should be built into eCare based on validity and ease of use I also led subcommittees that developed recommendations for which patient self-report surveys should be implemented for screening and monitoring of substance use disorders

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 16: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

16

borderline personality disorder bipolar disorder and dementia

Implementation and optimization of electronic medical records at McLean HospitalmdashMeditech and Partners HealthCare eCare (2009-present) (contrsquod)

bull I represent research interests on the Partners eCare Patient Engagement Committee the committee that implements the new electronic medical record patient portal and I co-chair its research sub-committee The portal provides opportunities for clinical and research-related patient-reported outcomes measurement In this role I represent and organize efforts related to using the patient electronic medical record portal (Patient Gateway) and other functional features of Epic to facilitate research represent McLean on the eCare Research Council and I have co-chaired the Councilrsquos Governance Subcommittee

bull As a member of the Partners eCare Privacy Committee I contributed to the organization-wide policy and privacy settings for psychiatry in the new electronic record balancing federal and state privacy requirements with healthcare coordination goals

McLean eCare Clinical Readiness Director I continue to represent McLean eCare needs at Partners eCare more broadly as McLeanrsquos Clinical Site Champion Additionally in March 2015 I became McLeanrsquos eCare Clinical Readiness Director In this role I have overarching responsibilities in the McLean specific eCare implementation including oversight of the McLean team of clinicians information systems analysts and process improvement professionals who are charged with determining what site-specific customizations we will need in the eCareEpic electronic medical record also how to optimize clinical workflows in light of new tools available in eCare

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present)

I direct McLeanrsquos Clinical Measurement Initiative (CMI) an electronic Patient Reported Outcomes Measurement (ePROMs) program in which patients complete computerized self-reported outcome measures as part of their routine care We use software traditionally used for research data capture (REDCap) and are applying it in a novel way that is for patient reported clinical outcomes in routine care The CMI has three goals 1) inform the routine care of individual patients 2) aggregate the data for population healthprogram outcomes assessment and 3) facilitate clinical research In the CMI programs implement a set of common surveys and select subspecialty-specific surveys relevant to a program population Each program implementation involves working closely with the clinical team to assist them in selecting valid feasible surveys that will meet the teamrsquos clinical population needs The CMI does not provide additional staffing resources for teams to accomplish the surveys so it is important to determine in advance what is feasible for teams given patient acuity length of stay and staffing constraints The CMI has been implemented in 17 of McLeanrsquos 18 partial hospitalresidential programs and the electroconvulsive therapy (ECT) service Continued implementations are ongoing Clinical innovations resulting from the CMI are

bull Established with a committee of McLean clinician researchers a core set of measures and clinical domains to be included in every program at McLean that implements the CMI These included measures of

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 17: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

17

depression tobacco alcohol and drug use disorders and functioning

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

This set of core measures provides a common set of clinical metrics implemented across patient sub-specialty populations to facilitate hospital program planning and population health management across McLean programspopulations

bull Developed individualized patient reports including the conceptual framework for how best to display the clinically relevant information (cross sectional and longitudinal) These reports are used to assist clinicians and patients in monitoring progress and outcomes during treatment

bull Developed aggregate data reports so that leadership from the individual programs can assess how routinely patients are completing the surveys and to facilitate program outcomes assessment and quality improvement Completion statistics help identify to the CMI team the clinical programs that need assistance in having their patients complete the assessments They also help the clinical program team leaders monitor progress and thereby improve the value of the aggregated population health outcomes for quality assessment and improvement The reports can also be used as a query tool to help clinical researchers assess the potential feasibility of potential observational research topics in terms of sample size data completion and baseline and discharge clinical outcomes

bull Provided data to support observational research for residents post-doctoral fellows and junior faculty resulting in dozens of peer reviewed published papers The data have also been included in grant proposals to the National Institute of Mental Health and private foundations

bull Tested the validity of a highly efficient single item drug screen in a psychiatric specialty care setting Prior to this study the most commonly used screen validated in psychiatric settings was a 10-item screen This study was published in the American Journal of Drug and Alcohol Abuse (Hearon et al 2015 reference 37 below) Pre-publication results were used to inform the Partners Psychiatry eCare Behavioral Health Assessments recommendations described above This study also enabled more efficient screening for drug use disorders at McLean and Partners eCare (ie one question versus ten) At McLean the 10-item screen has been replaced by this 1-item screen in the CMI Also the single item screen is now implemented as part of routine drug use disorder screening at McLeanrsquos admission center (independent of the CMI) At Partners these results influenced the Partners eCare Clinical Decision Support that was developed to facilitate drug use disorder screening Specifically after the eCare Clinical Decision Support Committee approved drug screening in psychiatric settings across Partners I then worked with the eCare informaticists to define how to

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 18: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

18

build the Clinical Decision Support based on the tools available in eCare and in consideration of usual care workflows in psychiatric settingsmdashusing this single item drug screen validated in the Clinical Measurement

Clinical Measurement Initiative (CMI) at McLean Hospital (2010-present) (contd)

Initiative as the screening measure to code into eCare to be available for clinician use in office visits

bull Tested the validity of the PHQ-9 in a psychiatric setting The PHQ-9 though widely used in healthcare settings to screen and monitor for depression has not previously been validated in a psychiatric setting Validating the single-item drug screen and the PHQ-9 in a psychiatric setting enables a common screening assessment between primary care and specialty psychiatric care This study was published (Beard et al 2016 reference 42 below)

bull Informed patient reported outcomes measurement at Partners HealthCare more broadly--based on the success of McLeanrsquos Clinical Measurement Initiative I was asked to present as an Invited Speaker at the Partners HealthCare Patient Reported Outcomes conference in November 2015

Report of Education of Patients and Service to the Community

Activities 2006 Health Consequences of Substance Use DisordersSingle presentation Harvard University Health Services--Drug and Alcohol Peer Advisors Report of Scholarship

Peer reviewed publications in print or other media 1 Busch AB Shore MF Seclusion and Restraint A Review of Recent Literature Harvard Review of

Psychiatry 20008(5)261-270 2 Cuffel BJ Azocar F Tomlin M Greenfield SF Busch AB Croghan TW Remission Residual

Symptoms and Nonresponse in the Usual Treatment of Major Depression in Managed Clinical Practice Journal of Clinical Psychiatry 200364(4)397-402

3 Busch AB Frank RG and Lehman AL The Effect of a Managed Behavioral Health Care Carve-Out on Quality of Care for Medicaid Patients Diagnosed with Schizophrenia Archives of General Psychiatry 200461(5)442-448

4 Frank RG Berndt ER Busch AB Lehman AF Quality Constant ldquoPricesrdquo for the Ongoing Treatment of Schizophrenia An Exploratory Study Quarterly Review of Economics and Finance 200444(3)390-409

5 Busch AB Frank RG Lehman AF Greenfield SF Schizophrenia Co-Occurring Substance Use Disorders and Quality of Care The Differential Effect of a Managed Behavioral Health Care Carve-Out Administration and Policy in Mental Health and Mental Health Services Research 200633(3)388-397

6 Goldman HH Frank RG Burnam MA Huskamp HA Ridgely MS Normand S-LT Young AS

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 19: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

19

Barry CL Azzone V Busch AB Azrin ST Moran G Lichtenstein C Blasinsky M Behavioral Health Insurance Parity for Federal Employees New England Journal of Medicine 2006354(13)1378-1385

7 Busch AB Huskamp HA Normand S-LT Young AS Goldman HH and Frank RG The Impact of Parity on Major Depression Treatment Quality in the Federal Employees Health Benefits Program Medical Care 200644(6)506-512

8 Berndt ER Busch AB Frank RG Normand S-LT Real Output in Mental Health Care During the 1990s Forum for Health Economics and Policy 20069(1)Article 5

9 Busch AB Ling DC Frank RG Greenfield SF Changes in Bipolar-I Disorder Quality of Care During the 1990s Psychiatric Services 200758(1)27-33

10 Azrin ST Huskamp HA Azzone V Goldman HH Frank RG Burnam MA Normand S-LT Ridgely MS Young AS Barry CL Busch AB Moran G Impact of Full Mental Health and Substance Abuse Parity for Children in the Federal Employees Health Benefits Program Pediatrics (electronic pages) 2007119(2)452-459

11 Busch AB Redlich AD Patients Perception of Possible Child Custody or Visitation Loss if Not Adherent to Psychiatric Treatment Psychiatric Services 200758(7)999-1002

12 Busch AB Huskamp HA Landrum MB Bipolar-I Disorder in a Medicaid Population Correlates of Quality of Care Psychiatric Services 200758(6)848-854

13 Busch AB Frank RG Sachs G Bipolar-I Depression Outpatient Treatment Quality and Costs in Usual Care Practice Psychopharmacology Bulletin 200841(2)24-39

14 Domino ME Maxwell J Cody M Cheal K Busch AB Van Stone WW Cooley SG Zubritsky C Estes CL Shen Y Lynch M Grantham S Wohlford P Aoyama MC Fitzpatrick J Zaman S Dodson J Levkoff SE The Influence of Integration on the Expenditures and Costs of Mental Health and Substance Use Care Results From the Randomized PRISM-E Study Ageing International (online) 2008

15 Busch AB Frank RG Sachs G Normand S-LT Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing Psychopharmacology Bulletin 200942(1)35-49

16 Busch AB Lehman AF Goldman HH Frank RG Changes Over Time and Disparities in Schizophrenia Treatment Quality Medical Care 200944(6)199-207

17 Huskamp HA Busch AB Domino ME Normand S-LT Antidepressant Reformulations Weighing Costs and Benefits Health Affairs 200928(3)734-745

18 Busch AB Huskamp HA Neelon B Manning T Normand S-LT McGuire T Longitudinal RacialEthnic Disparities in Antimanic Medication Use in Bipolar-I Disorder Medical Care 2009 47(12)1217-1228

19 Fullerton CA Busch AB Frank RG The Rise and Fall of Gabapentin for Bipolar Disorder A Case Study on Off-label Pharmaceutical Diffusion Medical Care 2010 48(4)372-379

20 Busch AB Wilder C van Dorn R Swanson J Swartz M Changes in Guideline Recommended Medication Possession After Implementing Kendras Law in New York Psychiatric Services 2010 61(10)1000-1005

21 Kozhimannil KB Adams AS Soumerai SB Busch AB Huskamp HA New Jerseyrsquos Efforts to Improve Postpartum Depression Care Did Not Change Treatment Patterns for Women on Medicaid Health Affairs201130(2)293-301

22 Conti R Busch AB Cutler D Overuse of Antidepressants Among a Nationally Representative

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 20: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

20

Adult Patient Population in 2005 Psychiatric Services 2011 62(7)720-726 23 Kozhimannil KB Trinacty CM Busch AB Huskamp HA Adams AS Racial and Ethnic

Disparities in Postpartum Depression Care Among Low-Income Women Psychiatric Services 2011 62(6)619-625

24 Yoon FB Huskamp HA Busch AB Normand S-LT Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research An Observational Study of the Effectiveness of Mental Health Parity Statistics in Biosciences 2011 3 63-78

25 Fullerton CA Busch AB Normand S-LT McGuire TG Epstein AM Ten-Year Trends in Quality and Spending for Depression 1996-2005 Archives of General Psychiatry 2011 68(12)1218-1226

26 Busch AB Neelon B Zelevinsky K He Y Normand SLT Accurately Predicting Bipolar Disorder Mood OutcomesmdashImplications for the Use of Electronic Medical Records Medical Care 2012 Apr50(4)311-319

27 Barry CL Normand S-LT Azzone V Busch AB Huskamp HA Economic Grand Rounds The Price is Right Changes in the Quantity of Services Used and Prices Paid in Response to Parity Psychiatric Services 2012 Feb 163(2)107-109

28 Dusetzina SB Busch AB Conti RM Donohue JM Alexander GC Huskamp HA Changes in Antipsychotic Use Among Patients With Severe Mental Illness After a Food and Drug Administration Advisory Pharmacoepidemiology and Drug Safety 2012(12)1251-1260

29 Fung V Price M Busch A Dow W Fireman B Hui R Landrum MB Frank R Newhouse J Hsu J CB7-02 Medicare Part D Cost-Sharing and Antipsychotic Drug Use in Two Medicare Advantage Systems Clinical Medical Research 2012 Aug 10(3)182

30 Dusetzina SB Cook B Busch AB Alexander GC Huskamp HA Effect of an FDA Advisory on Racial and Ethnic Disparities in Second Generation Antipsychotic Use Among Patients with Schizophrenia Psychiatric Services 201364(1)83-87

31 Busch AB Yoon F Barry CL Azzone V Normand S-LT Goldman HH Huskamp HA The Effects of Mental Health Parity on Spending and Utilization for Bipolar Major Depression and Adjustment Disorders American Journal of Psychiatry 2013170(2)180-187

32 Epstein AJ Busch SH Busch AB Asch DA Barry CL Does Exposure to Conflict of Interest Policies in Psychiatry Residency Affect Antidepressant Prescribing Medical Care 201351(2)199-203

33 Barry C Chien A Normand SL Busch AB Azzone V Goldman HH Huskamp HA Parity and Out-of-Pocket Spending for Children With High Mental Health or Substance Abuse Expenditures Pediatrics 2013 131(3)e903-e911

34 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg A Dow WH Hui R Frank RF Newhouse JP Hsu J Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs Linking Health Insurance Benefits and Clinical Needs Medical Care 201351(7)614-621

35

Burns ME Busch AB Madden J Le Cates R Zhang F Adams A Ross-Degnan D Soumerai SB Huskamp HA The Effect of Medicare Part D on the Quality of Pharmacotherapy for Bipolar-I Disorder Among Dually Enrolled Beneficiaries Psychiatric Services 2014 65(3)323-329

36 Boger KD Auerbach RP Pechtel P Busch AB Greenfield SF amp Pizzagalli DA Co-Occurring Depressive and Substance Use Disorders in Adolescents An Examination of Reward Responsiveness During Treatment Journal of Psychotherapy Integration 2014 23(2)109-121

37 Hearon BA Pierce CL Bjoumlrgvinsson T Fitzmaurice GM Greenfield SF Weiss RD Busch AB Improving the Efficiency of Drug Use Disorder Screening in Psychiatric Settings Validation of a

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 21: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

21

Single-Item Screen The American Journal of Drug and Alcohol Abuse 2015 41(2)173-176 38 Busch AB Epstein AM McGuire TG Normand S-LT Frank RG Thirty-Day Hospital

Readmission for Medicaid Enrollees With Schizophrenia The Role of Patient Characteristics and Local Health Care Systems The Journal of Mental Health Policy and Economics 2015 18(3)115-124

39 Busch AB He Y Zelevinsky K OrsquoMalley AJ Predicting Participation in Psychiatric Randomized Controlled Trials Insights From the STEP-BD Psychiatric Services 2015 166(8)817-823

40 OrsquoMalley AJ He Y Zelevinsky K Busch AB Do Patients at Sites With High RCT Enrollment Propensity Have Better Outcomes Medical Care 201543(11)989-995

41 Reddy M Schneiders-Rice S Pierce CL Fitzmaurice GT Busch AB Accuracy of Prospective Predictions for 30-Day Hospital Readmission Psychiatric Services 201667(2)244-7

42 Fung V Price M Busch AB Landrum MB Fireman B Nierenberg AA Newhouse JP Hsu J Am The introduction of generic risperidone in Medicare Part D J Manag Care 201622(1)41-8

43 Beard C Hsu KJ Rifkin LS Busch AB Bjorgvinsson T Validation of the PHQ-9 in a Psychiatric Sample Journal of Affective Disorders 2016 193267-273

44 Mehrotra A Jena AB Busch AB Souza J Uscher-Pines L Landon BE Utilization of Telemedicine Among Rural Medicare Beneficiaries JAMA 201635(18) 2015-2016

45 Montz E Layton T Busch AB Ellis RB Rose S McGuire TG Simulation of Marketplace Risk Adjustment Suggests Plans May Have Incentives to Distort Coverage for Mental Health or Substance Use Disorders Health Affairs 2016 35(6) 1022-1028

46 Busch AB Huskamp HA McWilliams JM Early Efforts By Medicare Accountable Care Organizations Have Limited Effect On Mental Illness Care And Management Health Affairs 201635(7)1247-1246

Non-peer reviewed scientific or medical publicationsmaterials in print or other media 1 Busch AB Marylandrsquos Medicaid Reform Will the Gain Outweigh the Pain Economic Grand

Rounds Psychiatric Services 199849(6)743-746 2 Busch AB Sederer LI Assessing Outcomes in Psychiatric Practice Guidelines Challenges and

Solutions Harvard Review of Psychiatry 20008(6)323-327 3 Busch AB Validity and Reliability and Other Key Concepts in Outcomes Assessment and Services

Research In Outcome Measurement in Psychiatry eds IsHak WW Burt T and Sederer LI Washington DC APPI Press 2001 pp 35-55

4 Busch AB Weiss RD and Najavits LM Co-Occurring Substance Use Disorders and Other Psychiatric Disorders In Clinical Textbook of Addictive Disorderseds Frances RJ Miller I and Mack S New York Guilford Publications 2005 pp 271-302

5 Busch AB Invited book review of American Psychosis How the Federal Government Destroyed the Mental Illness Treatment System by E Fuller Torrey American Journal of Psychiatry 2014171(11)1227-1228

6 Barry C Riedel L Busch AB Huskamp HA Early Insights from One Care Massachusettsrsquo Demonstration to Integrate Care and Align Financing for Dual Eligibles The Henry J Kaiser Family Foundation Issue Brief May 2015

Abstracts Poster Presentations and Exhibits Presented at Professional Meetings 1 Busch AB Laband A Kos A Weigel T Developing and Implementing an Electronic Patient

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 22: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

22

Reported Outcomes Measurement Program Using REDCap in Usual Care Psychiatric Settings Partners Connected Health Symposium 2016 Boston MA October 20-21 2016

Narrative Report My area of excellence is Investigation with significant supporting activities in Clinical Innovation Administration and Institutional Service at McLean and Partners HealthCare The overall theme of my activities is measuring and improving mental health treatment quality and outcomes in systems of care My research and hospital activities have influenced treatment quality nationally through my publications and participation on technical expert panels Programs under my direction have been used to develop and leverage electronic infrastructures to facilitate our scientific understanding of how to improve care and patient outcomes as well as to facilitate healthcare quality quality assessment and research at McLean and Partners HealthCare I currently devote 10 effort to direct clinical care 50 to hospital administration and 40 to research

My Investigation efforts focus on understanding how healthcare policy and financing affect quality of care for mental health and substance use disorders Much of my research uses administrative data to examine mental health treatment utilization quality and costs in a variety of diagnostic populations using Medicaid Medicare and private insurance data I am an expert in the development of process and outcome quality measures to understand how policy changes or system organizationcharacteristics are associated with differences in healthcare quality and utilization My research is nationally recognized I have served on an Institute of Medicine Committee and on several technical expert panels for developing national behavioral health quality measures for the Substance Abuse and Mental Health Administration Assistant Secretary for Planning and Evaluation Centers for Medicare and Medicaid Services Agency for Health Care Research and Quality and the National Committee for Quality Assurance I also now serve on the Quality Committee of the National Association of Psychiatric Health Care Systems

My supporting activities in Clinical Innovation Administration and Institutional Service also focus on healthcare quality and outcomes I direct activities that use clinical informatics to drive process improvement through workflow changes and optimization of McLeanrsquos electronic medical record to reduce medical errors and improve provider communication In this role I combine my knowledge of quality metrics with expertise in implementing and customizing electronic medical records to support the unique clinical content and workflow needs of psychiatric settings I have also made important contributions to the new Partners HealthCare eCare enterprise electronic medical record with specific leadership around ensuring that eCare has clinical decision support for the unique needs of psychiatric care and is more robust than what was previously available in the Partners legacy system the Longitudinal Medical Record (LMR) In addition my work directing McLeanrsquos Clinical Measurement Initiative is transforming care at our hospital In this Initiative we use research database software to electronically capture patient self-reported outcomes that inform routine clinical care for individual patients provide systematic outcomes information that can be used for quality assessment and improvement and spur clinical research Information gathered from the Clinical Measurement Initiative has also been used to innovate care by validating screening tools in psychiatric populations enabling more efficient assessments of patients at McLean and Partners Last year in recognition of my efforts to improve clinical process and outcomes through our growing electronic clinical systems I was appointed McLeanrsquos Chief Medical Information Officer In January 2017 I successfully completed the American Board of Preventive Medicine certifying examination and am board certified as a subspecialist in Clinical Informatics My expertise in applying clinical informatics to the unique needs in psychiatry now has national recognition I recently organized and was a panelist in an interactive panel at the 2016 American

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School
Page 23: Harvard Medical School Curriculum Vitae · 2015-2016 Technical Expert Panel, Inpatient Psychiatric Facility (IPF) Outcome and Process Measure Development and Maintenance Health Services

23

Medical Informatics Association Annual Symposium (AMIA) The panel ldquoMental HealthSubstance Use Disorder Care Privacy and HITmdashCan We Make it All Workrdquo discussed the ethical medical public health technical and policyregulatory challenges of health information technology privacy in the context of psychiatric care and the changing practice models of integrated coordinated healthcare Additionally in September 2016 I educated congressional staffers in Washington DC about how federal and state privacy regulations are challenging to apply in electronic health records and also pose conundrums when trying to provide safe coordinated care for patients with substance use disorders I have been invited to present our experiences in developing and implementing the electronic patient reported outcomes measurement program I direct at McLean the Clinical Measurement Initiative both locally (at the November 2015 Partners PROMs Summit) and in an international forum (the Third Meeting on Patient Reported Outcomes and Person Centered Care in Mental Health held in Washington DC September 2016) Recently I was asked to serve as an abstract reviewer for the 2017 AMIA Annual Symposium

My Teaching and Education contributions include educational seminars to residents about mental health policy and mentoring of pre- and post-doctoral researchers (resident psychiatrists psychiatrists nurses and social scientists) at McLean Hospital Massachusetts General Hospital and the Department of Health Care Policy

  • Harvard Medical School
  • Curriculum Vitae
  • Formal Teaching of Peers (eg CME and other continuing education courses)
  • Harvard Medical School